Lloyd Dean
About Lloyd Dean
Lloyd H. Dean, age 74, is Chief Executive Emeritus and Founding Executive of CommonSpirit Health and has served on McDonald’s board for 9 years. He is an independent director and currently chairs the Compensation Committee, with additional service on the Executive and Governance Committees . His background includes decades of CEO experience in large healthcare systems, with expertise spanning finance, human capital management, and sustainability/corporate responsibility .
Past Roles
| Organization | Role | Tenure | Committees/Impact |
|---|---|---|---|
| CommonSpirit Health | Chief Executive Officer | 2019–2022 | Led strategic, operational, and financial transformations; health/safety oversight |
| CommonSpirit Health | Chief Executive Emeritus and Founding Executive | 2022–Present | Senior advisory and leadership continuity |
| Dignity Health | President & CEO | 2000–2019 | Large-system leadership; finance, HR, systems operations experience |
External Roles
| Organization | Role | Tenure | Notes |
|---|---|---|---|
| Golden Arrow Merger Corp. | Director | Current | Public company board service |
| Progyny, Inc. | Director | Current | Public company board service |
Board Governance
- Independence: Board determined all non-management directors, including Dean, are independent under NYSE standards and the company’s independence criteria .
- Committee assignments and meeting cadence:
- Compensation Committee (Chair; met 4 times in 2024). Members: Dean (Chair), Capuano, Daniel, Mulligan, Taubert, White; scope includes executive pay design, risk assessment, incentive plan oversight, and clawback policy .
- Governance Committee (Member; met 8 times in 2024). Focus includes board structure, refreshment, succession, director pay guidelines, shareholder engagement, and governance risk oversight .
- Executive Committee (Member; met 0 times in 2024). May exercise board powers between meetings .
- Attendance and engagement: Board met 7 times in 2024; directors averaged 96% attendance across board and committee meetings (each director ≥75%); directors are expected to attend the annual meeting and executive sessions are held regularly without management .
- Board leadership structure: Combined Chairman/CEO (Kempczinski) with a strong Lead Independent Director (Miles White) and all standing committees (other than Executive) comprised of independent directors .
Fixed Compensation
- Director compensation program elements (effective 2024):
- Annual cash retainer: $120,000
- Equity: annual grant of common stock equivalent units valued at $205,000 (increase approved May 22, 2024)
- Committee chair retainers: $30,000 (Audit & Finance Chair); $25,000 for chairs of Compensation, Governance, Corporate Responsibility
- Additional: charitable match up to $10,000; option to defer cash retainer into common stock equivalent units under the Directors’ Plan; no perquisites >$10,000 for any director in 2024 .
| Director | Fees Earned in Cash ($) | Stock Awards ($) | All Other Compensation ($) | Total ($) |
|---|---|---|---|---|
| Lloyd Dean (Compensation Chair) | 145,000 | 203,060 | 10,000 | 358,060 |
Notes:
- Common stock equivalent units are credited at closing share price on grant date, track dividends and price changes notionally, and are settled in cash after board service ends; directors may elect deferrals with installment options up to 15 years .
Performance Compensation
- Directors do not receive performance-based pay. As Compensation Committee Chair, Dean oversees the executive incentive framework and targets.
| Plan | Metrics | Weights/Terms | 2024 Outcome/Notes |
|---|---|---|---|
| Short-Term Incentive Plan (STIP) | Operating Income Growth | 40% | Corporate STIP payout factor for NEOs: 27.6% for 2024 |
| STIP | Systemwide Sales Growth | 30% | Payout capped at 200% of target |
| STIP | New Restaurant Openings | 15% | Strategic growth emphasis |
| STIP | Strategic Scorecard | 15% | Values, engagement, franchising execution; cap 200% |
| Long-Term PRSUs | EPS Growth | 75% | 2022 awards vested early 2025 at 170.2% based on 2022–2024 performance |
| Long-Term PRSUs | ROIC | 25% | Three-year performance periods |
| TSR Modifier | Relative TSR vs S&P 500 | +/- 25 points | Applied to PRSU outcomes; options vest 25% per year, 10-year term |
Signals:
- Low STIP payout vs strong 3-year PRSU payout evidences pay-for-performance alignment managed by Dean’s committee .
Other Directorships & Interlocks
| Company | Relation to MCD | Potential Interlock/Conflict |
|---|---|---|
| Golden Arrow Merger Corp. | Unrelated SPAC | No related-party transactions disclosed involving Dean |
| Progyny, Inc. | Health benefits provider | No related-party transactions disclosed involving Dean |
- Outside board service policy limits directors to three public boards in addition to McDonald’s; notice and consent procedures required prior to joining another board .
Expertise & Qualifications
- Board skills matrix highlights Dean’s strengths in Brand Management, Customer-Centric operations, Finance/Capital Markets, Human Capital Management, Other Public Company Board experience, and Sustainability/Corporate Responsibility .
Equity Ownership
| Name | Common Stock | Stock Equivalents | Total | Ownership % of Common Shares Outstanding |
|---|---|---|---|---|
| Lloyd Dean | 0 | 14,104 | 14,104 | 0.000% (0/715,072,124 common shares outstanding) |
- Directors and executive officers as a group own less than 1% of common stock .
- Stock ownership guidelines: Directors must own shares equal to 5x annual cash retainer within five years; all directors are in compliance. Hedging and pledging of company stock are prohibited .
Governance Assessment
-
Strengths:
- Independence and committee leadership: Dean is an independent director leading the Compensation Committee; committees are fully independent with robust charters and risk oversight .
- Pay framework discipline: STIP metrics balance top-line/system health with strategic execution; PRSUs emphasize EPS/ROIC with TSR modifier; 2024 and 3-year outcomes show calibration and alignment .
- Attendance and engagement: High attendance across board/committees; regular executive sessions; structured shareholder engagement and Governance Committee oversight .
- Ownership alignment: Strict ownership guidelines met by all directors; hedging/pledging ban; deferral options link director economics to stock performance .
-
Watch items and conflicts:
- No related-party transactions disclosed involving Dean; board policy requires disclosure, review, and approval/ratification; pre-approved immaterial classes defined .
- Director equity is delivered as cash-settled common stock equivalent units (not voting shares), which reduces entrenchment risk but lessens direct voting-aligned ownership; mitigated by 5x retainer ownership guideline and compliance .
-
Compensation committee process quality:
- Committee membership breadth and use of independent consultant (Semler Brossy) for benchmarking and program review; director equity increased modestly in 2024 reflecting market data; clawback policy in place .
-
Overall signal: Dean’s leadership on Compensation appears aligned with shareholder interests given tight annual payouts amid below-target performance and strong multi-year outcomes; independence, attendance, and ownership policies support investor confidence .